March 13, 2015 — Researchers at the University of North Carolina (UNC) School of Medicine have found the blood platelet ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
March 11, 2015 — Point of Care Anticoagulation software (PCDS AC) optimizes delivery of anticoagulation (AC) drugs and ...
March 11, 2015
March 9, 2015 — Nearly all women and people over 65 in the United States with atrial fibrillation are advised to take bl ...
March 09, 2015March 6, 2015 — Merck announced results from two post-hoc analyses of the TRA 2°P TIMI 50 (Thrombin Receptor Antagonist ...
March 06, 2015
March 4, 2015 — The U.S. Food and Drug Administration (FDA) has approved the Xarelto Starter Pack for deep vein ...
March 04, 2015February 26, 2015 — Nanometer-sized “drones” could become a new way to prevent heart attacks caused by atherosclerosis ...
February 26, 2015February 26, 2015 — Patients who experienced a certain type of heart attack who received the anticoagulant fondaparinux ...
February 26, 2015
February 26, 2015 — By loading magnetic nanoparticles with drugs and dressing them in biochemical camouflage, Houston ...
February 26, 2015February 12, 2015 – Symphony Health Solutions (SHS) and the American College of Cardiology announced the completion of a ...
February 12, 2015February 4, 2015 — Millions of people take angiotensin receptor blockers (ARBs) to help treat heart failure. But it ...
February 04, 2015
January 22, 2015 — AstraZeneca announced that the PEGASUS-TIMI 54 study, a large-scale outcomes trial involving more ...
January 22, 2015
January 21, 2015 — A new post-marketing study evaluating the safety of once-daily rivaroxaban (Xarelto) shows, in ...
January 21, 2015The America College of Cardiology has released its list of key late-breaking clinical trials at the ACC 2015 meeting in ...
January 21, 2015
January 14, 2015 — More than 10 percent of patients treated with aspirin therapy for primary cardiovascular disease ...
January 14, 2015
January 12, 2015 — Daiichi Sankyo Co. Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved ...
January 13, 2015© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now